ESR1 and breast carcinoma: The comparison between luminal A and HER2-enriched subtypes shown in Fig 1d, also revealed rather distinct entities, where the markers ESR1 and HER2 (alias ERBB2) are main differentiators between these two molecular breast cancer subtypes.